Cite
APA Citation
Hannelius, U., Widman, M., & Ludvigsson, J. (2022). iDF21-0113 Design of a precision medicine GAD-alum immunotherapy Phase III clinical trial in Type 1 Diabetes. Diabetes research and clinical practice, 186, . http://access.bl.uk/ark:/81055/vdc_100156436030.0x000032